Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2100925 | Biochimica et Biophysica Acta (BBA) - Reviews on Cancer | 2013 | 9 Pages |
Abstract
Pancreatic cancer is the fourth leading cause of cancer deaths and is characterized by dismal prognosis. Xenograft and genetically engineered mouse (GEM) models have recapitulated critical elements of human pancreatic cancer, providing useful tools to probe the underlying cause of cancer etiology. In this review, we provide a brief description of the common genetic lesions that occur during the development of pancreatic cancer. Next, we describe the strengths and weaknesses of these two models and highlight key discoveries each has made. Although the relative merits of GEM and xenograft pancreatic cancer mouse models are subject to debate, both systems have and will continue to yield essential insights in understanding pancreatic cancer etiology. This information is critical for the development of new methods to screen, treat, and prevent pancreatic cancer.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Yuqing Zhang, Leon Chen, Jingxuan Yang, Jason B. Fleming, Paul J. Chiao, Craig D. Logsdon, Min Li,